GT Biopharma Inc. (GTBP)
NASDAQ: GTBP
· Real-Time Price · USD
1.49
0.15 (11.19%)
At close: Aug 18, 2025, 10:48 AM
GT Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -776K | -3.77M | -3.41M | -3.71M | -2.27M | -2.96M | -2.42M | -1.99M | -227K | -5.58M | -6.88M | -2.98M | -5.44M | -18.02M | -5.45M | -4.86M | -29.68M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | 8K | n/a | 120K | 102K | 453K | 500K | 398K | 822K | 1.33M | 2.9M | 463K | 1.32M | 8.02M | 901K | 904K | 24.1M |
Other Working Capital | -12K | 60K | -231K | 31K | -22K | -149K | -17K | -38K | -11K | 35K | 179K | 207K | -285K | -105K | -23K | 19K | 972K |
Other Non-Cash Items | -123K | 1.24M | -93K | -93K | -630K | 86K | -31K | -303K | -3.46M | -57K | 883K | 414K | 29K | -139K | -502K | 480K | 699K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.3M | 60K | 767K | 147K | -1.37M | 376K | -17K | -38K | -40K | 13K | 179K | -684K | -1.12M | 6.43M | 1.13M | -811K | 1.19M |
Operating Cash Flow | -2.2M | -2.47M | -2.74M | -3.54M | -4.16M | -2.05M | -1.96M | -1.94M | -2.91M | -4.3M | -2.92M | -2.79M | -5.21M | -3.71M | -3.93M | -4.29M | -3.68M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | 7.86M | n/a | n/a | 5.03M | 478K | 1.84M | 2.66M | -6.99M | n/a | n/a | n/a | n/a | 2.99M | -26.03M | n/a | n/a |
Sales Maturities Of Investments | n/a | -5.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25K | 1.08M | 3.53M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -2.82M | -1K | 7.86M | n/a | n/a | n/a | n/a | n/a | 7.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 1K | -1K | 7.86M | 5.03M | 478K | 1.84M | 2.66M | -6.99M | 7.51M | 25K | 1.08M | 3.53M | 2.99M | -26.03M | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.21M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | -223K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 616K | n/a | n/a | n/a | n/a | -400K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 58K |
Financial Cash Flow | 616K | n/a | n/a | 2.98M | n/a | -400K | n/a | n/a | 6.27M | -1K | n/a | -223K | n/a | n/a | 137K | 16.24M | 25.94M |
Net Cash Flow | -1.59M | -2.47M | -2.74M | 7.3M | 871K | -1.57M | -119K | 722K | -3.63M | 3.21M | -2.89M | -1.93M | -1.68M | -714K | -29.82M | 11.95M | 22.26M |
Free Cash Flow | -2.2M | -2.47M | -2.74M | -3.54M | -4.16M | -2.05M | -1.96M | -1.94M | -2.91M | -4.3M | -2.92M | -2.79M | -5.21M | -3.71M | -3.93M | -4.29M | -3.68M |